triheptanoin (Dojolvi) Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA

Active Ingredient History

  • Now
Triheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data
glyceroltriheptanoate | glyceryl triheptanoate | triheptanoin | triheptanoin oil


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue